Renovaro ( NASDAQ: RENB ) has announced that it has $10M in additional equity committed at a price per share of $1.4726 and 10 percent warrant coverage. “We believe this is only the beginning.
We are hopeful to be able to secure additional financing such as, but not limited to, long-term loans, grants and subsidies from various US and European institutions for which the Co. is eligible – potentially worth tens of millions of dollars.” said the Hon.
Mark Dybul, MD, CEO. More on Renovaro Inc. RenovaroCube to acquire 100% ownership of Cyclomics Financial information for Renovaro Inc.
.
